However, it has been demonstrated that, in the setting of obesity, SFRP5 secretion by adipocytes exerts salutary effects on metabolic dysfunction by controlling inflammatory cells within adipose tissue [76]. This evidence concerns the gene SFRP5 and obesity due to melanocortin 4 receptor deficiency.